Under New CEO, GSK Will Leverage OTCs In Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Glaxo will look at opportunities to expand its nonprescription business, as OTC and other products have more long-term sales consistency than Rx drugs, North American Pharmaceuticals President Viehbacher says.